Follow us:

Tel: +44 (0) 1904 406082

About B-cell dyscrasias

B-cell dyscrasias are disorders of the plasma cells, characterised by the abnormal proliferation of a monoclonal population of plasma cells that may or may not secrete detectable levels of a monoclonal immunoglobulin or immunoglobulin fragment (paraprotein or M protein).

This group includes multiple myeloma, monoclonal gammopathy of undetermined significance (MGUS), solitary plasmacytoma of bone, extramedullary plasmacytoma, Waldenström’s macroglobulinemia (WM), primary amyloidosis, light chain deposition disease, paraproteinemia, and heavy-chain disease.

Abingdon Health is addressing unmet clinical needs in this area with the introduction of rapid and near patient tests for diagnosis and monitoring of B-cell dyscrasias. The first product to market is Seralite® – FLC, a device for the quantitative analysis of free light chains.

Seralite® – FLC Serum

Rapid test for the quantitative measurement of free light chains (FLCs) in diagnosis and monitoring of multiple myeloma.

Discover Seralite® - FLC

Seralite® – FLC Urine

  A rapid test for the quantitative measurement of kappa (K) and […]

Read More

Seralite® – FLC ELISA

Accurate measurement of both kappa and lambda free light chains (FLCs) across a diverse range of patient cohorts.

Discover Seralite® - FLC ELISA